EDVANYSEBeveragesFiscal year ends December 31
Endovia Health Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)
Close on Oct 19, 2026
- Market cap
- $413.76K
- P/E (TTM)
- –
- Dividend yield
- –
Endovia Health Sciences, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 21 | Q3 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Splash Beverage Group [Member] | $0 | $4.22K | – | $369.67K | $0 | $9.59K | $398.51K | $886.87K | $1.02M | $1.20M | $1.11M | $960.38K | – | – |
| E Commerce [Member] | – | – | $0 | $23.36K | $0 | $59.01K | $187.38K | $94.99K | $23.38K | $340.40K | $1.95M | $1.87M | – | – |
By region
From the segment and revenue-disaggregation notes of Endovia Health Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.